Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 83930-13-6
2. Somatorelin [inn]
3. Unii-4ur7n9z9mm
4. 4ur7n9z9mm
5. Grf (1-44), Human
6. Dtxsid40232828
7. Growth Hormone-releasing Factor (human)
Molecular Weight | 5040 g/mol |
---|---|
Molecular Formula | C215H358N72O66S |
XLogP3 | -27.2 |
Hydrogen Bond Donor Count | 83 |
Hydrogen Bond Acceptor Count | 76 |
Rotatable Bond Count | 183 |
Exact Mass | 5038.6658354 g/mol |
Monoisotopic Mass | 5036.6591258 g/mol |
Topological Polar Surface Area | 2360 Ų |
Heavy Atom Count | 354 |
Formal Charge | 0 |
Complexity | 12500 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 44 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
V04CD05
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
V - Various
V04 - Diagnostic agents
V04C - Other diagnostic agents
V04CD - Tests for pituitary function
V04CD05 - Somatorelin
Global Sales Information
ABOUT THIS PAGE
A Growth-hormone-releasing hormone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Growth-hormone-releasing hormone, including repackagers and relabelers. The FDA regulates Growth-hormone-releasing hormone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Growth-hormone-releasing hormone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Growth-hormone-releasing hormone supplier is an individual or a company that provides Growth-hormone-releasing hormone active pharmaceutical ingredient (API) or Growth-hormone-releasing hormone finished formulations upon request. The Growth-hormone-releasing hormone suppliers may include Growth-hormone-releasing hormone API manufacturers, exporters, distributors and traders.
Growth-hormone-releasing hormone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Growth-hormone-releasing hormone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Growth-hormone-releasing hormone GMP manufacturer or Growth-hormone-releasing hormone GMP API supplier for your needs.
A Growth-hormone-releasing hormone CoA (Certificate of Analysis) is a formal document that attests to Growth-hormone-releasing hormone's compliance with Growth-hormone-releasing hormone specifications and serves as a tool for batch-level quality control.
Growth-hormone-releasing hormone CoA mostly includes findings from lab analyses of a specific batch. For each Growth-hormone-releasing hormone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Growth-hormone-releasing hormone may be tested according to a variety of international standards, such as European Pharmacopoeia (Growth-hormone-releasing hormone EP), Growth-hormone-releasing hormone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Growth-hormone-releasing hormone USP).
LOOKING FOR A SUPPLIER?